skip to main content
Show Results with:

6 results  for Everything in this catalogue

Refined by: author: Teng, Zhaoyang remove
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Material Type:
Article
Add to My workspace

Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma

Kumar, Shaji K. et al.

British journal of haematology. Volume 184:Number 4 (2019, February); pp 536-546 -- Wiley

Online access

2
Material Type:
Article
Add to My workspace

Phase 2 Study of the All-Oral Combination of Ixazomib Plus Cyclophosphamide and Low-Dose Dexamethasone (ICd) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Kumar, Shaji et al.

Clinical lymphoma, myeloma & leukemia. Volume 17:Issue 1 (2017) Supplement; pp e131- -- Elsevier

Online access

3
Material Type:
Article
Add to My workspace

An Open-label, Phase 2 Study to Evaluate the Oral Combination of Ixazomib, Cyclophosphamide, and Dexamethasone (ICd) in Transplant-Ineligible Patients with Newly Diagnosed Multiple Myeloma (NDMM)

Dimopoulos, Meletios et al.

Clinical lymphoma, myeloma & leukemia. Volume 17 (2017) Supplement 2; pp S333-S334 -- Elsevier

Online access

4
Material Type:
Article
Add to My workspace

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Dimopoulos, Meletios A. et al.

European journal of cancer. Volume 106: (2019, January); pp 89-98 -- Elsevier

Online access

5
Material Type:
Article
Add to My workspace

Phase 2 study of all‐oral ixazomib, cyclophosphamide and low‐dose dexamethasone for relapsed/refractory multiple myeloma

Kumar, Shaji K.

British journal of haematology. Volume 184:Number 4 (2019); pp 536-546 -- Wiley

Online access

6
Material Type:
Article
Add to My workspace

All-oral ixazomib, cyclophosphamide, and dexamethasone for transplant-ineligible patients with newly diagnosed multiple myeloma

Dimopoulos, Meletios A. et al.

European journal of cancer. Volume 106 (2019); pp 89-98 -- Elsevier

Online access

6 results  for Everything in this catalogue

Refine Search Results

Searching Remote Databases, Please Wait